SCHEMBL28060314

SCHEMBL28060314

CCC(=O)C(C)(Br)C(=O)OC

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.37
KCNN4 O15554 1/20 0.33
POLB P06746 2/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
SRC P12931 1/20 0.31
PRSS1 P07477 2/20 0.30
CTSG P08311 2/20 0.30
CTRB1 P17538 2/20 0.30
CMA1 P23946 2/20 0.30
NPSR1 Q6W5P4 2/20 0.30
HPGD P15428 1/20 0.30
TSHR P16473 1/20 0.30
MAPK1 P28482 1/20 0.30
ATM Q13315 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4300520 0.80 DGAT1 (0.46) DGAT1KCNN4ALDH1A1LMNAKMT2A
SCHEMBL4463173 0.76 DGAT1 (0.50) DGAT1KCNN4POLBALDH1A1TSHR
SCHEMBL25946813 0.73 FFAR3 (0.38) ALDH1A1KMT2ATSHR
SCHEMBL21687493 0.73 DGAT1 (0.41) DGAT1KCNN4ALDH1A1LMNAKMT2A
SCHEMBL988428 0.73 KCNN4 (0.41) DGAT1KCNN4ALDH1A1LMNAKMT2A
SCHEMBL3169320 0.73 DGAT1 (0.37) DGAT1POLBALDH1A1NPSR1HPGD
SCHEMBL17611270 0.73 DGAT1 (0.37) DGAT1ALDH1A1KMT2AGAA
SCHEMBL27820854 0.73 DGAT1 (0.37) DGAT1NPSR1HPGDTSHRMAPK1
SCHEMBL1854077 0.71
SCHEMBL27580351 0.71 DGAT1 (0.45) DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116583501-A Compounds and compositions for treating conditions associated with LPA receptor activity 罗特斯生物公司 2023-08-11 CN disclosed
CN-104540826-B Spiro-fused piperidine derivatives useful as inhibitors of extrarenal potassium channels 默沙东公司 2018-04-20 CN disclosed
CN-107074843-A heteroaromatic compounds and their use as dopamine D1 ligands 辉瑞公司 2017-08-18 CN disclosed
CN-105324376-B Heteroaromatics and its purposes as dopamine D 1 part 辉瑞大药厂 2017-06-23 CN disclosed
CN-105612162-A Thiazolopyrimidinones as modulators of NMDA receptor activity HOFFMANN LA ROCHE 2016-05-25 CN disclosed